Kinesiophobia in Patients With Implanted Left Ventricular Assist Devices
Kinesiophobia Affects Functional Capacity in Patients With Implanted Left Ventricular Assist Devices
1 other identifier
interventional
37
1 country
1
Brief Summary
The goal of this prospective and cross-sectional observational study is to learn if the presence and changes in kinesiofobia (fear of movement) affect functional capacity levels in heart failure patients who are transplant candidates and have been implanted with a Left Ventricular Assist Device (LVAD). The main questions it aims to answer are: i) Does the level of kinesiofobia change significantly 1 month after LVAD implantation? ii) Do changes in kinesiofobia levels predict changes in functional exercise capacity (measured by the 2-Minute Walk Test and 30-Second Sit-to-Stand Test)? Researchers will compare pre-discharge (baseline) measurements to 1-month post-discharge follow-up measurements to see if improvements in kinesiofobia correlate with improved functional mobility and endurance. Participants will: i) Complete the Tampa Scale of Kinesiofobia (TSK) to assess their fear of movement. ii) Perform the 2-Minute Walk Test (2MWT) to evaluate functional exercise capacity and mobility. iii) Perform the 30-Second Sit-to-Stand Test (30STS) to determine functional endurance and lower extremity performance. iv) Receive standardized physical activity recommendations upon discharge. v) Return for a follow-up assessment one month later to repeat the same battery of tests.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 4, 2026
CompletedFirst Submitted
Initial submission to the registry
January 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 4, 2026
CompletedFirst Posted
Study publicly available on registry
February 6, 2026
CompletedFebruary 10, 2026
January 1, 2026
1.1 years
January 30, 2026
February 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Tampa Kinesiophobia Scale
The Tampa Scale of Kinesiofobia (TSK) is a widely used patient-reported outcome measure designed to quantify a patient's fear of movement and fear of (re)injury. It was originally developed to assess patients with chronic low back pain, but it has since been validated for various populations. It is a 17-item questionnaire where each item is scored on a 4-point Likert scale, ranging from "strongly disagree" to "strongly agree". While cut-off values can vary by population, a score higher than 37 is often considered to represent high kinesiofobia.
From enrollment to the 4 weeks after the implementation
Secondary Outcomes (2)
2-Minute Walk Test
From enrollment to the 4 weeks after the implementation
30 Seconds Sit to Stand Test (30STS)
From enrollment to the 4 weeks after the implementation
Study Arms (1)
Exercise Recommendation Group
EXPERIMENTALPatient who recevied physical activity recommendations after LVAD implementation
Interventions
Patients with implanted LVADs will be given recommendations for physical activities they can incorporate into their daily lives.
Eligibility Criteria
You may qualify if:
- Being a heart transplant candidate and having undergone LVAD implantation,
- Having a left ventricular ejection fraction (LVEF) \<30%,
- Not having developed any surgical or medical complications in the early period after implantation,
- Being referred to the study by a cardiologist at the time of discharge,
- Being able to read and write and volunteering to participate in the study.
You may not qualify if:
- Those with evidence of active infection following implantation,
- Psychiatric problems developing after LVAD implantation that interfere with cognitive adaptation,
- Musculoskeletal problems developing after LVAD implantation,
- Cases experiencing acute cardiac problems requiring hospitalization during follow-up.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Marmara University Faculty of Health Sciences
Istanbul, 34854, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
January 30, 2026
First Posted
February 6, 2026
Study Start
December 2, 2024
Primary Completion
January 4, 2026
Study Completion
February 4, 2026
Last Updated
February 10, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share